The Research and Development Division at EEPI aspires to transform drug development by applying innovative approaches to enhance quality and productivity of development and significantly decrease the time frame associated with the introduction of new products to the market.
Our R&D division covers the following activities: |
| |
 |
|
Product Development
Our Product Development team carries out feasibility studies and pharmaceutical development of products recommended by the new product committee. The team also supervises the product validation process of approved products, and manages trouble-shooting during production. The team is also responsible for developing new formulae for the broad spectrum portfolio of different pharmaceutical groups & forms produced in EEPI using innovative methods. |
 |
Methodology Development
Our Methodology Development team improves and validates routine and stability-indicating analytical procedures. Analytical methods validation follows international standards and norms and used for all EEPI products. |
|
Stability Studies
Our Stability Studies team performs long term and accelerated stability studies for Pre and Post registration and ongoing stability studies for products in production. The aim is to recommend suitable storage conditions and to determine product shelf-life.
The Stability Studies protocol is prepared in guidance with ICH requirements and WHO guidelines. |
|
Product Registration
Our Registration team is responsible for preparing all documents required by the Ministry of Health and Population (MoH) for the registration of new products, renewals and modification of the registration files when needed. The team also prepares export files and fulfillment of the registration requirements for export to different countries. |
